Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Search Results
Ketamine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
02/16/2018
»Therapeutic Categories: Anesthesia
Eugia US LLC (Reverified 10/04/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 55150-438-10) | Available | Check wholesalers for inventory | |
| Injection, 50 mg/1 mL (NDC 55150-439-10) | Unavailable | Intermittent availability expected | Demand increase for the drug |
| Injection, 100 mg/1 mL (NDC 55150-440-10) | Unavailable | Intermittent availability expected | Demand increase for the drug |
Fresenius Kabi USA, LLC (Reverified 10/02/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 10 mg/1 mL (NDC 65219-184-20) | Available | Check wholesaler inventory | |
| Injection, 50 mg/1 mL (NDC 65219-188-10) | Available | Check wholesaler inventory |
Gland Pharma Limited (Revised 07/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketamine Hydrochloride, Injection, 10 mg/1 mL (NDC 25021-682-20) | Available | Distributed by Sagent Pharmaceuticals: 1-866-625-1618 | |
| Ketamine Hydrochloride, Injection, 50 mg/1 mL (NDC 25021-683-10) | Available | Distributed by Sagent Pharmaceuticals: 1-866-625-1618 | |
| Ketamine Hydrochloride, Injection, 100 mg/1 mL (NDC 25021-684-05) | Available | Distributed by Sagent Pharmaceuticals: 1-866-625-1618 |
Hikma Pharmaceuticals USA, Inc. (Reverified 09/25/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketamine HCl Injection, USP, Injection, 50 mg/1 mL (NDC 0143-9508-10) | Available | ||
| Ketamine HCl Injection, USP, Injection, 100 mg/1 mL (NDC 0143-9509-10) | Available |
Hospira, Inc., a Pfizer Company (Revised 10/03/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 0409-2051-05) | Available | ||
| Injection, 500 mg/5 mL (100 mg/mL) (NDC 0409-0040-10) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: September 2024 | Delay in shipping of the drug |
| Ketamine Hydrochloride, Injection, 500 mg/10 mL (50 mg/mL) (NDC 0409-2053-10) | Unavailable | Next Delivery: January 2025; Estimated Recovery: March 2025 | Delay in shipping of the drug |
Par Pharmaceutical, Inc. (Reverified 10/03/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Ketalar, Injection, 10 mg/1 mL (NDC 42023-113-10) | Available | ||
| Ketalar, Injection, 100 mg/1 mL (NDC 42023-115-10) | Unavailable | Recovery: TBD | Shortage of an active ingredient |
| Ketalar, Injection, 50 mg/1 mL (NDC 42023-114-10) | Unavailable | Recovery: TBD | Shortage of an active ingredient |